Evidence map›Paper›PMID 41996282›Full record

ArticleDiabetes2026

Co-occurrence of Loss-of-Function GCK and ABCC8 Variants in a Pedigree With a Spectrum of Dysglycemia.

Cécile Saint-Martin, Assmaa ElSheikh, Sophie Jacqueminet, Jean-Baptiste Arnoux, Cécile Ciangura, Christine Bellanné-Chantelot, Show-Ling Shyng

Abstract read
In one paragraph

Article in Diabetes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Cécile Saint-MartinDepartment of Medical Genetics, Pitié-Salpêtrière Hospital, Sorbonne University, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.
Assmaa ElSheikhDepartment of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR.
Sophie JacqueminetDiabetology Department, Pitié-Salpêtrière Hospital, Sorbonne University, AP-HP, Paris, France.
Jean-Baptiste ArnouxDepartment of Inherited Metabolic Disease, Necker-Enfants Malades University Hospital, AP-HP, Paris, France.
Cécile CianguraDiabetology Department, Pitié-Salpêtrière Hospital, Sorbonne University, AP-HP, Paris, France.
Christine Bellanné-ChantelotDepartment of Medical Genetics, Pitié-Salpêtrière Hospital, Sorbonne University, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris, France.ORCID 0000-0001-8415-6771
Show-Ling ShyngDepartment of Chemical Physiology and Biochemistry, Oregon Health & Science University, Portland, OR.ORCID 0000-0002-8230-8820

Funding

Structural Basis of KATP Channel GatingR01DK066485 · NIDDK · OREGON HEALTH & SCIENCE UNIVERSITY · PI SHYNG, SHOW-LING · 2006 to 2024
$5.8M
Experimental Therapeutics in Cancer Training ProgramT32CA285265 · NCI · OREGON HEALTH & SCIENCE UNIVERSITY · PI Shivaani Kummar, SANJAY V. MALHOTRA · 2025 to 2026
$450k
Egyptian GM 1109NCI NIH HHS T32CA285265NIDDK NIH HHS R01 DK066485NIDDK NIH HHS R01DK066485
6 · The paper itself

Abstract

Glucokinase and ATP-sensitive potassium (KATP) channels in pancreatic β-cells control insulin secretion in response to glucose stimulation to maintain glucose homeostasis. It is well established that loss-of-function (LOF) variants in GCK, which encodes glucokinase, are diabetogenic, whereas LOF variants in KATP channel genes lead to congenital hyperinsulinism (HI) and hypoglycemia. However, how the co-occurrence of GCK and KATP channel variants manifests in glycemic phenotypes is unknown. This study presents a multiplex pedigree with a heterozygous GCK deletion along with a heterozygous ABCC8 variant that results in the E1209K missense variant in the regulatory subunit of the KATP channel sulfonylurea receptor 1 (SUR1). The three-generation pedigree exhibits a complex spectrum of dysglycemia depending on genotype and age at referral. Individuals harboring the heterozygous GCK deletion alone present with maturity-onset diabetes; those harboring the heterozygous ABCC8 E1209K variant alone exhibit HI resulting from the LOF of KATP channels, with some developing diabetes later in life; and those harboring both GCK and ABCC8 variants escape HI but not diabetes. This unique pedigree offers insights into the complex interplay between LOF genetic variants of glucokinase and KATP channels in age-dependent dysglycemia. ARTICLE HIGHLIGHTS: Genetic variants causing loss of function (LOF) of glucokinase or ATP-sensitive potassium (KATP) channels underlie diabetes or congenital hyperinsulinism, respectively, but how the co-occurrence of such variants affects glucose control is unknown. This study presents genotypes and clinical phenotypes in a pedigree with LOF variants in both GCK and the pancreatic KATP channel. Heterozygous glucokinase deletion masked infantile hyperinsulinemia and hypoglycemia caused by a heterozygous LOF KATP channel variant. Carriers of the LOF KATP variant exhibited a shift from hypoglycemia to diabetes, as has been reported previously in some carriers of KATP LOF variants.

Indexed as

Germinal Center KinasesGlucokinaseLoss of Function MutationSulfonylurea ReceptorsCongenital HyperinsulinismDiabetes Mellitus, Type 2FemaleHeterozygoteHumansMalePedigreeABCC8 protein, humanGerminal Center KinasesGlucokinaseSulfonylurea Receptors

Identifiers

PMID41996282
PMCPMC13178161

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.